Q2 Earnings Estimate for BCLI Issued By Zacks Small Cap
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Free Report) – Zacks Small Cap issued their Q2 2025 earnings per share estimates for shares of Brainstorm Cell Therapeutics in a report issued on Tuesday, May 27th. Zacks Small Cap analyst D. Bautz anticipates that the biotechnology company will earn ($0.41) per share for the quarter. The consensus […]
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Free Report) – Zacks Small Cap issued their Q2 2025 earnings per share estimates for shares of Brainstorm Cell Therapeutics in a report issued on Tuesday, May 27th. Zacks Small Cap analyst D. Bautz anticipates that the biotechnology company will earn ($0.41) per share for the quarter. The consensus […]
